10Panx是一种多肽类、竞争性的Pannexin 1（PANX1）通道选择性抑制剂。其通过抑制PANX1通道的开放，进而阻断ATP释放及其下游的P2X7受体信号通路，最终发挥减少细胞死亡和炎症反应的作用。基于此机制，10Panx在神经病理性疼痛、炎症性肠病及艰难梭菌感染等疾病模型中展现出治疗潜力，具体表现为有效缓解机械痛觉过敏、抑制C反射增强以及降低IL-6等促炎因子的表达。

/

-85~-65℃避光保存，有效期2年。

[1] Loureiro AV, Moura-Neto LI, Martins CS, Silva PIM, Lopes MBS, Leitão RFC, Coelho-Aguiar JM, Moura-Neto V, Warren CA, Costa DVS, Brito GAC. Role of Pannexin-1-P2X7R signaling on cell death and pro-inflammatory mediator expression induced by Clostridioides difficile toxins in enteric glia. Front Immunol. 2022 Aug 22;13:956340. doi: 10.3389/fimmu.2022.956340. PMID: 36072579; PMCID: PMC9442043.

[2]Bravo D, Zepeda-Morales K, Maturana CJ, Retamal JS, Hernández A, Pelissier T, Barra R, Sáez-Briones P, Burgos H, Constandil L. NMDA and P2X7 Receptors Require Pannexin 1 Activation to Initiate and Maintain Nociceptive Signaling in the Spinal Cord of Neuropathic Rats. Int J Mol Sci. 2022 Jun 16;23(12):6705. doi: 10.3390/ijms23126705. PMID: 35743148; PMCID: PMC9223805.